Physician

Robert Byron Osborne, MD

According to 2025 Medicare claims, Robert Osborne, MD (NPI: 1962481556) practices urology in the Charlottesville, VA market, with the plurality of this provider's patient population coming from Albemarle, VA. This provider's primary affiliated billing organization is UROLOGICAL ASSOCIATES, LTD (NPI: 1700810397; TIN: 540892025) and primary practice location at 22911-8607.

Osborne's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 911 traditional Medicare patients, billed 16,155 HCPCS/CPT codes, and received $374,414 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,150 prescription claims across 482 beneficiaries totaling $141,129 in drug costs, led by Silodosin (Silodosin). DME data shows 28 claims. Open Payments data shows 72 records totaling $1,630. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	710	13,231	$335,429
2016	770	14,939	$334,685
2017	817	14,462	$344,512
2018	776	12,143	$329,851
2019	822	11,472	$286,086
2020	887	12,262	$324,509
2021	1,101	17,255	$416,247
2022	1,134	15,793	$418,091
2023	1,114	16,078	$415,705
2024	911	16,155	$374,414

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	333	1,795	$200,994
2016	381	1,914	$245,915
2017	402	2,200	$340,937
2018	385	2,064	$369,910
2019	405	1,961	$427,020
2020	410	1,987	$542,329
2021	435	2,024	$551,059
2022	445	2,075	$405,824
2023	455	2,013	$261,565
2024	482	2,150	$141,129

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	22	$5,644
2016	N/R	38	$3,969
2017	N/R	77	$6,891
2018	N/R	39	$6,064
2019	N/R	77	$46,732
2020	N/R	51	$51,792
2021	N/R	17	$27,142
2022	N/R	52	$23,575
2023	N/R	62	$36,762
2024	N/R	28	$43,273

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	481	862	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	520	714	$62
36415	Insertion of needle into vein for collection of blood sample	446	683	$9
51798	Ultrasound measurement of bladder capacity after voiding	422	633	$8
81001	Manual urinalysis test with examination using microscope, automated	836	1,707	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Silodosin	Silodosin	378	22,427	$33,162
Myrbetriq	Mirabegron	23	990	$15,165
Gemtesa	Vibegron	19	840	$12,882
Trimethoprim	Trimethoprim	88	7,228	$7,744
Finasteride	Finasteride	357	30,574	$5,340

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	28	$43,273

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	72	$1,630	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert Byron Osborne, MD?

Tedicare shows public-source Medicare data for Robert Byron Osborne, MD (NPI 1962481556), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Byron Osborne, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Byron Osborne, MD?

Robert Byron Osborne, MD is linked to UROLOGICAL ASSOCIATES, LTD (billing NPI 1700810397) in the available physician profile data.

Does Robert Byron Osborne, MD have Open Payments data?

Robert Byron Osborne, MD has 72 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.